PIEZO1 and digestive system neoplasm: Although current evidence supports Piezo1 as a mechanosensory oncogenic hub in various gastrointestinal tumors, the downstream effectors involved (Rho, MCU, p53, YAP, metabolic enzymes) differ significantly between tissues, indicating that its function is co-shaped by the mechanical and metabolic microenvironment.